Xiaolong Qi
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 1%
- Liver Disease and Transplantation
Papers in
- Hepatology 58
- Liver Disease and Transplantation 49
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Epidemiology 67
- Liver Disease Diagnosis and Treatment 60
Xiaolong Qi
168 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Cancer Research 1.9k
- Hepatology 739
- Modeling and Simulation 285
- Infectious Diseases 978
- Oncology 1.0k
Countries citing papers authored by Xiaolong Qi
This map shows the geographic impact of Xiaolong Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Qi more than expected).
Fields of papers citing papers by Xiaolong Qi
This network shows the impact of papers produced by Xiaolong Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Qi. The network helps show where Xiaolong Qi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaolong Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 5 | |
| 6 | 2025 | 0 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 75 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 4 | |
| 14 | 2020 | 45 | |
| 15 | 2019 | 1 | |
| 16 | 2018 | 21 | |
| 17 | 2018 | 4 | |
| 18 | 2018 | 0 | |
| 19 | A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors | 2014 | 13 |
| 20 | 2013 | 2 |
About Xiaolong Qi
Xiaolong Qi is a scholar working on Hepatology, Epidemiology, Surgery, Urology and Oncology, having authored 189 papers that have together received 6.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (60 papers), Liver Disease and Transplantation (49 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Organ Transplantation Techniques and Outcomes (15 papers), Gastric Cancer Management and Outcomes (11 papers), MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (9 papers) and Urological Disorders and Treatments (8 papers). The work is most often cited by research in Cancer Research (1.9k citations), Hepatology (739 citations), Modeling and Simulation (285 citations), Infectious Diseases (978 citations) and Oncology (1.0k citations). Xiaolong Qi has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Nan Wu, Wang Ma, Dahong Zhang, Junhua Xiao, Xiang Wang, David Baud, Karin Nielsen‐Saines, Didier Musso, Léo Pomar and Guillaume Favre. Their work appears in journals such as Oncotarget, Hepatology International, Annals of Translational Medicine, European Journal of Surgical Oncology and Archives of Medical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.